118 related articles for article (PubMed ID: 3000136)
1. A novel 8-phenyl-substituted xanthine derivative is a selective antagonist at adenosine A1-receptors in vivo.
Jakobson KA; Kirk KL; Daly JW; Jonzon B; Li YO; Fredholm BB
Acta Physiol Scand; 1985 Oct; 125(2):341-2. PubMed ID: 3000136
[No Abstract] [Full Text] [Related]
2. Evidence that a novel 8-phenyl-substituted xanthine derivative is a cardioselective adenosine receptor antagonist in vivo.
Fredholm BB; Jacobson KA; Jonzon B; Kirk KL; Li YO; Daly JW
J Cardiovasc Pharmacol; 1987 Apr; 9(4):396-400. PubMed ID: 2438501
[TBL] [Abstract][Full Text] [Related]
3. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
Schwabe U; Ukena D; Lohse MJ
Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):212-21. PubMed ID: 2997628
[TBL] [Abstract][Full Text] [Related]
4. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
Shimada J; Suzuki F; Nonaka H; Ishii A
J Med Chem; 1992 Mar; 35(5):924-30. PubMed ID: 1548682
[TBL] [Abstract][Full Text] [Related]
5. 1,3-Dipropyl-8-cyclopentylxanthine (DPCPX) inhibition of [3H]N-ethylcarboxamidoadenosine (NECA) binding allows the visualization of putative non-A1 adenosine receptors.
Lee KS; Reddington M
Brain Res; 1986 Mar; 368(2):394-8. PubMed ID: 3008930
[TBL] [Abstract][Full Text] [Related]
6. PD 116,948, a highly selective A1 adenosine receptor antagonist.
Haleen SJ; Steffen RP; Hamilton HW
Life Sci; 1987 Feb; 40(6):555-61. PubMed ID: 3807648
[TBL] [Abstract][Full Text] [Related]
7. 125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors.
Linden J; Patel A; Earl CQ; Craig RH; Daluge SM
J Med Chem; 1988 Apr; 31(4):745-51. PubMed ID: 3351850
[TBL] [Abstract][Full Text] [Related]
8. Biochemical characterization of the antagonist actions of the xanthines, PACPX (1,3-dipropyl-8(2-amino-4-chloro)phenylxanthine) and 8-PT (8-phenyltheophylline) at adenosine A1 and A2 receptors in rat brain tissue.
Williams M; Jarvis MF; Sills MA; Ferkany JW; Braunwalder A
Biochem Pharmacol; 1987 Nov; 36(22):4024-7. PubMed ID: 3689436
[No Abstract] [Full Text] [Related]
9. Thermoregulatory effects of 5'-N-ethylcarboxamidoadenosine in rabbits.
Matuszek MT; Gagalo IT
Ann N Y Acad Sci; 1997 Mar; 813():360-8. PubMed ID: 9100907
[No Abstract] [Full Text] [Related]
10. Inhibition by xanthine derivatives of adenosine receptor-stimulated cyclic adenosine 3',5'-monophosphate accumulation in rat and guinea-pig thymocytes.
Fredholm BB; Sandberg G
Br J Pharmacol; 1983 Dec; 80(4):639-44. PubMed ID: 6100843
[TBL] [Abstract][Full Text] [Related]
11. Adenosine receptor mediated increases and decreases in cyclic AMP in hippocampal slices treated with forskolin.
Fredholm BB; Jonzon B; Lindström K
Acta Physiol Scand; 1983 Mar; 117(3):461-3. PubMed ID: 6308960
[No Abstract] [Full Text] [Related]
12. Agonist and antagonist affinities for inhibitory adenosine receptors are reciprocally affected by 5'-guanylylimidodiphosphate or N-ethylmaleimide.
Yeung SM; Green RD
J Biol Chem; 1983 Feb; 258(4):2334-9. PubMed ID: 6296141
[No Abstract] [Full Text] [Related]
13. Hypotensive and renal vasodilator effects of carbocyclic adenosine (aristeromycin) in anesthetized spontaneously hypertensive rats.
Dunham EW; Vince R
J Pharmacol Exp Ther; 1986 Sep; 238(3):954-9. PubMed ID: 3018227
[TBL] [Abstract][Full Text] [Related]
14. Theophylline-like properties of xanthine analogs.
Levallois C; Bonnafous JC; Francoise MA; Sablayrolles C; Chapat JP; Mani JC
Biochem Pharmacol; 1984 Jul; 33(14):2253-7. PubMed ID: 6087821
[TBL] [Abstract][Full Text] [Related]
15. Effect of adenosine receptor agonists and other compounds on cyclic AMP accumulation in forskolin-treated hippocampal slices.
Fredholm BB; Jonzon B; Lindström K
Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):173-8. PubMed ID: 3010142
[TBL] [Abstract][Full Text] [Related]
16. The effects of parenteral injections of adenosine and its analogs on blood pressure and heart rate in the rat.
Barraco RA; Marcantonio DR; Phillis JW; Campbell WR
Gen Pharmacol; 1987; 18(4):405-16. PubMed ID: 3038667
[TBL] [Abstract][Full Text] [Related]
17. Subtypes of adenosine receptors in the brainstem mediate opposite blood pressure responses.
Barraco RA; Phillis JW
Neuropharmacology; 1991 Apr; 30(4):403-7. PubMed ID: 1852271
[TBL] [Abstract][Full Text] [Related]
18. Release of atrial natriuretic factor induced by the A1 adenosine receptor agonist 2-chloro-N6-cyclopentyl-adenosine in the rat.
Massi M; Saija A; Cristalli G; Polidori C; Perfumi M; Costa G
Pharmacol Res; 1992; 25(4):393-402. PubMed ID: 1409251
[TBL] [Abstract][Full Text] [Related]
19. Differences in the properties of A1-type adenosine receptors in rat white and brown adipocytes.
Saggerson ED; Jamal Z
Biochem J; 1990 Jul; 269(1):157-61. PubMed ID: 2375749
[TBL] [Abstract][Full Text] [Related]
20. The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.
Nicholson CD; Jackman SA; Wilke R
Br J Pharmacol; 1989 Jul; 97(3):889-97. PubMed ID: 2474352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
